Deciphering the TLR4 and NLRP3 Inflammasome Crosstalk for Therapeutic Restoration of Intestinal and Systemic Immunity.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing mechanistic concepts and preclinical literature without systematic search methodology
PubMed 41518448 · doi:10.1007/s10620-025-09655-y
What was done
This narrative review synthesized recent literature regarding the regulatory mechanisms and crosstalk between Toll-like receptor 4 (TLR4) and the NLRP3 inflammasome in gastrointestinal homeostasis and pathology. The authors evaluated preclinical and mechanistic studies spanning epithelial barrier function, cytokine signaling, pyroptosis, metabolic endotoxemia, dysbiosis, and gut-brain axis communication, including model systems such as organoids, gut-on-a-chip platforms, and multi-omics approaches.
What was found
The abstract reports no numerical data, effect estimates, or statistical findings. It conceptually describes that homeostatic TLR4-NLRP3 signaling maintains mucosal integrity and immune tolerance, whereas dysregulated signaling initiates a feed-forward cycle of epithelial damage, dysbiosis, and cytokine-mediated inflammation implicated in inflammatory bowel disease, necrotizing enterocolitis, colorectal cancer, obesity, type 2 diabetes, and neuroinflammation.
Why it matters
It highlights the TLR4-NLRP3 axis as a dual regulator of intestinal and systemic immunity, summarizing emerging therapeutic strategies such as selective small-molecule inhibitors and microbiome-directed interventions.
Limits
The review provides purely qualitative and mechanistic descriptions without original empirical data or quantitative metrics. As a narrative review, it lacks systematic search methodology, formal study quality assessment, and direct human clinical outcome data.
Cited by
- supports Localized intestinal inflammation triggers the release of systemic cytokines that transmit inflammatory signals to other organ systems throughout the body.